CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Wedbush Lifts Price Target on Benitec Biopharma to $17 From $16, Keeps Outperform Rating

Positive
AI Analysis

Summary

Wedbush increased its price target on Benitec Biopharma from $16 to $17 while maintaining an Outperform rating.

Importance:2/10
Sentiment:
0.30
price_targetanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on September 15, 2026 10:48 AM

Read Original